Latest News about GSK
Recent news which mentions GSK
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
December 08, 2022
From Benzinga
GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial
December 07, 2022
From Benzinga
From Benzinga
From Benzinga
GSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as ‘best-case scenario’
December 07, 2022
From MarketWatch
These 3 Stocks Escaped Tuesday's Market Downdraft
December 06, 2022
From Motley Fool
Why GSK Plc And Sanofi SA Stock Are Shooting Higher
December 06, 2022
From Benzinga
Tickers
GSK
From MarketWatch
From Benzinga
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
From Benzinga
After Disappointing Confirmatory Study, GSK To Withdraw Approved Blood Cancer Drug In US
November 22, 2022
Tickers
GSK
From Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
FDA Moves Step Closer For Opioid Overdose Medication Access, Says Certain Naloxone Products Can Potentially Be Used In OTC Setting
November 15, 2022
From Benzinga
GSK Touts Encouraging Data From Mid-Stage Tuberculosis Program In Drug-Susceptible Patients
November 14, 2022
Tickers
GSK
From Benzinga
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
November 11, 2022
Tickers
GSK
From MarketWatch
GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations
November 11, 2022
Tickers
GSK
From Benzinga
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
From Benzinga
From MarketWatch
GSK's Conditionally Approved Blood Cancer Drug Fails On Progression-Free Survival Goal Over Standard Care
November 07, 2022
Tickers
GSK
From Benzinga
Why Vir Biotechnology Jumped Nearly 19% Today
November 04, 2022
From Motley Fool
Moderna's Earnings Collapsed. Time to Sell?
November 04, 2022
From Motley Fool
Citing Efficacy, GSK Stops Two Pivotal UTI Antibiotic Trials Early
November 03, 2022
Tickers
GSK
From Benzinga
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02
November 02, 2022
From Benzinga
Tickers
GSK
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.